Drugs / PNU-IMUNE®23
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00133549 | Nov 2000 → Dec 2002 | pneumococcal infection | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PNU-IMUNE23 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00133549 ↗ |
| Modality | Vaccine | “The 23-valent pneumococcal vaccine (PS) vaccine” NCT00133549 ↗ |
| Route | Intramuscular | “The vaccine will be administered in a volume of 0.5 ml intramuscularly.” NCT00133549 ↗ |